Please see full Prescribing Information, including BOXED WARNING, at trodelvysafetyhcp.com and Important Safety Information in the pinned post below. For US HCPs only. TRODELVY is a Gilead product and is not associated with any individual users.
To report SUSPECTED ADVERSE REACTIONS, contact Gilead Sciences, Inc. at 1-800-445-3235 or FDA at 1-800-FDA-1088 or fda.gov/medwatch
Company Details
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- https://www.TRODELVYHCP.com
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp Questions
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp's website is https://www.TRODELVYHCP.com
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp's LinkedIn profile is https://www.linkedin.com/company/trodelvyhcp
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp's industry is
Pharmaceutical Manufacturing
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp's top competitors are
Sanofi,
Gilead Sciences,
Abbvie,
Stryker,
Argenx,
Bristol Myers Squibb,
Keytruda® (Pembrolizumab) Hcp,
Biktarvy® (Bictegravir 50/emtricitabine 200mg/tenofovir Alafenamide 25mg) Tablets Hcp,
Catalyst Pharmaceuticals, Inc.,
Avadel Pharmaceuticals Plc.
Trodelvy® (Sacituzumab Govitecan-Hziy) Hcp's categories are Pharmaceutical Manufacturing
